HCM
ASXC

Highbridge Capital Management’s Asensus Surgical, Inc. ASXC Stock Holding History

Highbridge Capital Management’s Portfolio ASXC Stock Details ASXC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-4,580
Closed -$135K – 1873
2015
Q3 		$135K Buy
+4,580
New +$170K ﹤0.01% 1415

Other funds holding ASXC

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Highbridge Capital Management's ASXC Position: Q4 2015 in Review

Highbridge Capital Management sold out of Asensus Surgical, Inc. (ASXC) in Q4 2015, closing a stake of 4,580 shares — an estimated $135K sold.

Highbridge Capital Management first reported a position in ASXC in Q3 2015 and held it in 1 quarter. The position peaked at $135K in Q3 2015. 64 funds tracked by Wall St. Rank hold ASXC as of Q4 2015.

  • Highbridge Capital Management reported no remaining Asensus Surgical, Inc. position as of Q4 2015 after selling out during the quarter.
  • Highbridge Capital Management sold 4,580 Asensus Surgical, Inc. shares in Q4 2015, an estimated $135K.
  • Highbridge Capital Management first reported a position in Asensus Surgical, Inc. in Q3 2015 and held it in 1 quarter.
  • Highbridge Capital Management's Asensus Surgical, Inc. position peaked at $135K in Q3 2015.
  • 64 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2015.

Based on Highbridge Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.